Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C)
Bell et al., Clinical Drug Investigation, doi:10.1007/s40261-024-01344-4
https://c19early.org/bell3.html